These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15946813)

  • 21. Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter.
    Kazi AA; Jones JM; Koos RD
    Mol Endocrinol; 2005 Aug; 19(8):2006-19. PubMed ID: 15774498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K; Banerjee S; Saxena N; Banerjee SK
    Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the chemically synthesized flavanone 7-(O-prenyl)naringenin-4'-acetate on the estrogen signaling pathway in vivo and in vitro.
    Kretzschmar G; Vollmer G; Schwab P; Tischer S; Metz P; Zierau O
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):114-9. PubMed ID: 17631998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo.
    Steinmetz R; Brown NG; Allen DL; Bigsby RM; Ben-Jonathan N
    Endocrinology; 1997 May; 138(5):1780-6. PubMed ID: 9112368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen-like activity of aqueous extract from Agrimonia pilosa Ledeb. in MCF-7 cells.
    Lee YM; Kim JB; Bae JH; Lee JS; Kim PS; Jang HH; Kim HR
    BMC Complement Altern Med; 2012 Dec; 12():260. PubMed ID: 23259680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
    Jeng MH; Langan-Fahey SM; Jordan VC
    Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.
    Stoner M; Wormke M; Saville B; Samudio I; Qin C; Abdelrahim M; Safe S
    Oncogene; 2004 Feb; 23(5):1052-63. PubMed ID: 14647449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes.
    Jørgensen M; Vendelbo B; Skakkebaek NE; Leffers H
    Environ Health Perspect; 2000 May; 108(5):403-12. PubMed ID: 10811566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogenic activity of naturally occurring anthocyanidins.
    Schmitt E; Stopper H
    Nutr Cancer; 2001; 41(1-2):145-9. PubMed ID: 12094617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin.
    Liu X; Zhang F; Liu H; Burdette JE; Li Y; Overk CR; Pisha E; Yao J; van Breemen RB; Swanson SM; Bolton JL
    Chem Res Toxicol; 2003 Jun; 16(6):741-9. PubMed ID: 12807357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.
    Heneweer M; Muusse M; Dingemans M; de Jong PC; van den Berg M; Sanderson JT
    Toxicol Sci; 2005 Feb; 83(2):257-63. PubMed ID: 15525692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oestrogenic activity of isobutylparaben in vitro and in vivo.
    Darbre PD; Byford JR; Shaw LE; Horton RA; Pope GS; Sauer MJ
    J Appl Toxicol; 2002; 22(4):219-26. PubMed ID: 12210538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters.
    Zacharewski TR; Meek MD; Clemons JH; Wu ZF; Fielden MR; Matthews JB
    Toxicol Sci; 1998 Dec; 46(2):282-93. PubMed ID: 10048131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the estrogenic activities of pesticides from Pal-dang reservoir by in vitro assay.
    Oh YJ; Jung YJ; Kang JW; Yoo YS
    Sci Total Environ; 2007 Dec; 388(1-3):8-15. PubMed ID: 17904202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells.
    Chang M; Peng KW; Kastrati I; Overk CR; Qin ZH; Yao P; Bolton JL; Thatcher GR
    Endocrinology; 2007 Oct; 148(10):4793-802. PubMed ID: 17584965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells.
    Weaver CA; Springer PA; Katzenellenbogen BS
    Mol Endocrinol; 1988 Oct; 2(10):936-45. PubMed ID: 2460749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Royal jelly stimulates bone formation: physiologic and nutrigenomic studies with mice and cell lines.
    Narita Y; Nomura J; Ohta S; Inoh Y; Suzuki KM; Araki Y; Okada S; Matsumoto I; Isohama Y; Abe K; Miyata T; Mishima S
    Biosci Biotechnol Biochem; 2006 Oct; 70(10):2508-14. PubMed ID: 17031045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tamoxifen exerts agonistic effects on clusterin and complement C3 gene expression in RUCA-I primary xenografts and metastases but not normal uterus.
    Zierau O; O'Sullivan J; Morrissey C; McDonald D; Wünsche W; Schneider MR; Tenniswood MP; Vollmer G
    Endocr Relat Cancer; 2004 Dec; 11(4):823-30. PubMed ID: 15613455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.